Caphosol is a CE marked Class I Medical device.

Caphosol is indicated for dryness of the mouth and oropharynx (hyposalivation, xerostomia), regardless of the cause and regardless of whether the condition is temporary or permanent.

Caphosol is also indicated as an adjunct to standard oral care in the prevention and treatment of the mucositis that may be caused by radiation or high dose chemotherapy. Relief of dryness of the oral mucosa in these conditions is associated with amelioration of pain.

Further information for Caphosol can be found at www.caphosol.eu

An FDA-approved medical device, CAPHOSOL is a topical oral agent indicated in the U.S. as an adjunct to standard oral care in treating oral mucositis caused by radiation or high dose chemotherapy.

CAPHOSOL is also indicated for dryness of the mouth (hyposalivation) or dryness of the throat (xerostomia) regardless of the cause or whether the conditions are temporary or permanent.

Full prescribing information for CAPHOSOL can be found at www.caphosol.com

Collatamp a lyophilized bovine or equine collagen sponge impregnated with the aminoglycoside antibiotic gentamicin, is indicated for local haemostasis of capillary, parenchymatous and seeping haemorrhages in areas with a high risk of infection.

¹ available but not registered.

Erwinase is used in combination with other anti-neoplastic agents to treat Acute Lymphoblastic Leukemia. It may also be used in other neoplastic conditions where depletion of asparagine might be expected to have a useful effect. Patients receiving treatment with L-asparaginase derived from Escherichia coli, who develop hypersensitivity to that enzyme, may be able to continue treatment with ERWINASE as the enzymes are immunologically distinct. (UK SmPC)

¹ Local Marketing Authorisation Holder : the Health Protection Agency

² Erwinase is not yet fully approved in these countries but upon the request of a physician, Erwinase may be made available to named patients who fulfil a defined criteria.

³ Erwinase is not yet registered in these countries but upon the request of a physician, Erwinase may be made available to named patients who fulfil a defined criteria.

⁴ Only available as part of a treatment IND.

This specific pharmacological antidote is indicated for the treatment of ^*ethylene glycol poisoning.

* This compound is commonly used in antifreeze.

KIDROLASE is indicated in the treatment of Acute Lymphoblastic Leukaemia, Leukaemic meningitis and Non-Hodgkin’s lymphoma.

* Kidrolase is not approved in these countries but upon the request of a physician, Kidrolase may be made available to named patients who fulfil a defined criteria

PROSTASCINT is a PSMA-targeting monoclonal antibody-based agent to image the extent and spread of prostate cancer.

Full prescribing information for PROSTASCINT can be found at www.prostascintimaging.com

QUADRAMET is a radiopharmaceutical for the treatment of pain in patients whose cancer has spread to the bone.

Full prescribing information for QUADRAMET can be found at
www.quadrametinfo.com

Xenazine was developed by Cambridge Laboratories (UK) and is indicated for the treatment of movement disorders associated with Huntington’s chorea and Hemiballismus.